✦ LIBER ✦

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years

✍ Scribed by Massimo Fasano; Pietro Lampertico; Alfredo Marzano; Vito Di Marco; Grazia Anna Niro; Giuseppina Brancaccio; Andrea Marengo; Gaetano Scotto; Maurizia Rossana Brunetto; Giovanni Battista Gaeta; Mario Rizzetto; Gioacchino Angarano; Teresa Santantonio

Book ID: 116652721
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 541 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.01.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of response to entecavir ther

Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels

✍ J. W. Shin; S. W. Jung; B. R. Park; C. J. Kim; J. B. Eum; B. G. Kim; I. D. Jeong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5&#xa0;years

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years